Medicine guide

WEZENLA

As listed in the register: WEZENLA 45 mg, solution injectable en seringue préremplie

45 mg · solution injectable

  • Prescription only
Active substance
Ustékinumab
Made by
AMGEN TECHNOLOGY (IRELAND)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Details

Made byAMGEN TECHNOLOGY (IRELAND)
Active substanceUstékinumab
Strength45 mg
Formsolution injectable
Routesous-cutanée
Dispensing (as stated by the register)prescription réservée aux spécialistes et services HEPATO/GASTRO-ENTEROLOGIE · prescription réservée aux spécialistes et services MEDECINE INTERNE · prescription réservée aux spécialistes et services RHUMATOLOGIE · prescription réservée aux spécialistes et services DERMATOLOGIE · liste I
MarketedYes, according to the register
Reinforced monitoringYes — under reinforced monitoring, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/24/1823
Name in the registerWEZENLA 45 mg, solution injectable en seringue préremplie
Packs1 seringue préremplie en verre de 0,5 mL
CIS61082122
CIP133400930295496

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Other strengths and forms

6 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.